Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Apimeds Pharmaceuticals US, Inc. ( (APUS) ) has provided an announcement.
On December 5, 2025, Apimeds Pharmaceuticals US, Inc. announced the resignation of Dr. Vin Menon and Amir A. Dossal from its Board of Directors. Their departures were amicable, with no disagreements regarding the company’s operations, policies, or practices.
More about Apimeds Pharmaceuticals US, Inc.
Average Trading Volume: 107,141
Technical Sentiment Signal: Strong Sell
Current Market Cap: $26.79M
See more data about APUS stock on TipRanks’ Stock Analysis page.